Furthermore, the clinical relevance of these findings was underscored in analyses of human primary tumors which revealed that high expression of the Irf7-regulated genes in patients with BC was associated with less relapses to bone (Bidwell et al., 2012). This evidence concerns the gene IRF7 and breast cancer.